Comparative Analysis of Different Inbred Chicken Lines Highlights How a Hereditary Inflammatory State Affects Susceptibility to Avian Influenza Virus
Overview
Authors
Affiliations
Evidence suggests that susceptibility to avian influenza A virus in chickens is influenced by host genetics, but the mechanisms are poorly understood. A previous study demonstrated that inbred line 0 chickens are more resistant to low-pathogenicity avian influenza (LPAI) infection than line CB.12 birds based on viral shedding, but the resistance was not associated with higher AIV-specific IFNγ responses or antibody titres. In this study, we investigated the proportions and cytotoxic capacity of T-cell subpopulations in the spleen and the early immune responses in the respiratory tract, analysing the innate immune transcriptome of lung-derived macrophages following in vitro stimulation with LPAI H7N1 or the TLR7 agonist R848. The more susceptible C.B12 line had a higher proportion of CD8αβ γδ and CD4CD8αα αVβ T cells, and a significantly higher proportion of the CD8αβ γδ and CD8αβ αVβ T cells expressed CD107a, a surrogate marker of degranulation. Lung macrophages isolated from line C.B12 birds expressed higher levels of the negative regulator genes and whereas macrophages from line 0 birds expressed higher levels of antiviral genes including and . After stimulation with R848, the macrophages from line 0 birds mounted a higher response compared to line C.B12 cells. Together, the higher proportion of unconventional T cells, the higher level of cytotoxic cell degranulation ex vivo and post-stimulation and the lower levels of antiviral gene expression suggest a potential role of immunopathology in mediating susceptibility in C.B12 birds.
Delineation of chicken immune markers in the era of omics and multicolor flow cytometry.
Hartle S, Sutton K, Vervelde L, Dalgaard T Front Vet Sci. 2024; 11:1385400.
PMID: 38846783 PMC: 11156169. DOI: 10.3389/fvets.2024.1385400.
Chicken intestinal organoids: a novel method to measure the mode of action of feed additives.
Mitchell J, Sutton K, Elango J, Borowska D, Perry F, Lahaye L Front Immunol. 2024; 15:1368545.
PMID: 38835764 PMC: 11148291. DOI: 10.3389/fimmu.2024.1368545.
Chen L, Hua J, He X BMC Genomics. 2024; 25(1):257.
PMID: 38454348 PMC: 10918912. DOI: 10.1186/s12864-024-10184-7.
Sutton K, Nash T, Sives S, Borowska D, Mitchell J, Vohra P Front Microbiol. 2023; 14:1258796.
PMID: 37854334 PMC: 10579587. DOI: 10.3389/fmicb.2023.1258796.